Comprehensive Genomic Profiling and HRD Testing in Ovarian samples: Speakers

Dr. Elaine Wong Ho, PHD
Role: Sr. Product Manager, Oncology
Organisation: Thermofisher Scientific
Location: United States

Genomic Instability Metric (GIM) for HRD Assessment
Elaine Wong-Ho is the Senior Product Marketing Manager in Thermofisher scientific, and is part of the Clinical Sequencing division overseeing Oncology. She is recognized for her extensive experience across multiple disciplines, from R&D, to Applications Development, through Sales and Marketing. She has deep expertise in Oncology specializing in next-generation sequencing technologies, targeted resequencing, and clinical applications of Genomics and has published several clinical papers and presented in numerous conferences with her deep knowledge in the field of oncology malignancies.

Nicola Normanno, MD
Role: Director, Translational Research
Organisation: National Cancer Institute, Italy Pascale Foundation
Location: Italy

Future Clinical Perspective of HRD Testing in Ovarian Cancer Samples using Next Generation Sequencing Comprehensive Genomic Profiling
Dr. Nicola Normanno is the Director of Translational research in National Cancer institute, Italy Pascale Foundation. He holds the positions of President at the International Quality Network for Pathology (IQN Path) and Italian Cancer Society (SIC). He has several clinical publications and presented in numerous conferences with his deep expertise in the field of oncology and next generation seqeuncing techniques.